Cite
HARVARD Citation
Meany, H. et al. (2021). Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors. Pediatric blood & cancer. 68 (11), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Meany, H. et al. (2021). Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors. Pediatric blood & cancer. 68 (11), p. n/a. [Online].